title: Treatment of Idiopathic Pulmonary Fibrosis.
authors.affiliation: 1 Division of Pulmonary, Critical Care, Sleep, and Occupational Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
authors.forename: William G
authors.initials: WG
authors.lastname: Carlos
authors.affiliation: 2 The University of Chicago, Pulmonary and Critical Care Medicine, Chicago, Illinois.
authors.forename: Mary E
authors.initials: ME
authors.lastname: Strek
authors.affiliation: 3 Department of Medicine, Division of Pulmonary and Critical Care Medicine, Ronald Reagan University of California, Los Angeles Medical Center, Los Angeles, California.
authors.forename: Tisha S
authors.initials: TS
authors.lastname: Wang
authors.affiliation: 4 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Harin
authors.initials: H
authors.lastname: Patel
authors.affiliation: 5 Division of Pulmonary and Critical Care Medicine, University of Washington Medical Center, Seattle, Washington; and.
authors.forename: Ganesh
authors.initials: G
authors.lastname: Raghu
authors.affiliation: 6 Department of Medicine, Boston University, Boston, Massachusetts.
authors.forename: Kevin C
authors.initials: KC
authors.lastname: Wilson
authors.affiliation: 4 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Carey C
authors.initials: CC
authors.lastname: Thomson
mesh_terms: D055317:Evidence-Based Practice; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000188:drug therapy*; D054539:Medication Therapy Management